Delivery at 34 Weeks: Late Preterm Risks, Indications, and Decision-Making

34 weeks = late preterm. This is not term (39–40 weeks). Delivery should be driven by clear maternal or fetal indications, not convenience.

Neonatal Outcomes at 34 Weeks

  • Survival: >99% with NICU support.
  • Morbidities: Respiratory distress syndrome (30–40%), feeding difficulties, temperature instability, jaundice, apnea, sepsis risk, and higher rehospitalization rates.
  • Long-term: Small but measurable increases in neurodevelopmental delay and learning disabilities compared to term infants.

Indications for Delivery

  • Maternal: Severe preeclampsia, HELLP syndrome, placental abruption, uncontrolled diabetes, chorioamnionitis.
  • Fetal: IUGR with abnormal Dopplers, non-reassuring fetal testing, complications of multiple gestation.

If No Indication Exists

  • Continue pregnancy with surveillance (NST, AFI, growth scans).
  • Administer corticosteroids (betamethasone) if delivery anticipated before 37 weeks to accelerate lung maturity.
  • Magnesium sulfate for neuroprotection if <32 weeks (some protocols extend to 34 weeks).

Shared Decision-Making

Discuss risks of continuing versus delivering with maternal-fetal medicine and obstetrics. Document indication clearly. Avoid elective delivery before 39 weeks.

Pregnancy & Health - Related Articles